Mini-Reviews in Medicinal Chemistry
Title:Meet Our Editorial Board Member
Volume: 19 Issue: 13
Author(s): Roberto Di Santo
Affiliation:
Export Options
About this article
Cite this article as:
Di Santo Roberto , Meet Our Editorial Board Member, Mini-Reviews in Medicinal Chemistry 2019; 19 (13) . https://dx.doi.org/10.2174/138955751913190626113224
DOI https://dx.doi.org/10.2174/138955751913190626113224 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
15
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nitric Dioxide as Biologically Important Radical and its Role in Molecular Mechanism of Pancreatic Inflammation
Current Pharmaceutical Analysis Editorial
Central Nervous System Agents in Medicinal Chemistry Inside the Pan-genome - Methods and Software Overview
Current Genomics Non Nucleoside Reverse Transcriptase Inhibitors, Molecular Docking Studies and Antitubercular Activity of Thiazolidin-4-one Derivatives
Current Computer-Aided Drug Design Identification of Thiazoloquin(az)olin(on)es Derivatives as CD38 Inhibitors Through 3D-QSAR and Molecular Docking Simulations
Letters in Drug Design & Discovery Green Synthesis of Gold Nanoparticles Using Different Leaf Extracts of Ocimum gratissimum Linn for Anti-tubercular Activity
Current Nanomedicine Meet Our Editorial Board Member:
Current Medicinal Chemistry Fused Aryl-Phenazines: Scaffold for the Development of Bioactive Molecules
Current Drug Targets Bioactive Compounds for Effective Management of Drug-Resistant Tuberculosis
Current Bioactive Compounds Multiplication of <i>Mycobacterium tuberculosis</i> in Peripheral Blood of Mice and Effect of Anti-tubercular Drugs on Bacteremia
Letters in Drug Design & Discovery Recent Patents on Live Bacteria and their Products as Potential Anticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Activation of Macrophages: Establishing a Role for Polysaccharides in Drug Delivery Strategies Envisaging Antibacterial Therapy
Current Pharmaceutical Design Th17 and Treg Cells, Two New Lymphocyte Subpopulations with a Key Role in the Immune Response Against Infection
Infectious Disorders - Drug Targets Controlling Biofilms of Gram-Positive Pathogenic Bacteria
Current Medicinal Chemistry Structural Basis for Inhibition of Enoyl-[Acyl Carrier Protein] Reductase (InhA) from Mycobacterium tuberculosis
Current Medicinal Chemistry Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review
Current Rheumatology Reviews Inflammatory Bowel Disease: New Therapeutic Options in the Post Anti-TNFα Era
Current Drug Metabolism TNF-α in Tuberculosis: A Cytokine with a Split Personality
Inflammation & Allergy - Drug Targets (Discontinued) Editorial (Thematic Issue: New Developments in the Search for Agents to Treat Tuberculosis)
Current Topics in Medicinal Chemistry Identification of Selectivity Determinants in CYP Monooxygenases by Modelling and Systematic Analysis of Sequence and Structure
Current Drug Metabolism